333 related articles for article (PubMed ID: 31757716)
1. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4
Fu J; Shi H; Wang B; Zhan T; Shao Y; Ye L; Wu S; Yu C; Zheng L
J Autoimmun; 2020 Feb; 107():102358. PubMed ID: 31757716
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren's Syndrome.
Fu J; Pu Y; Wang B; Li H; Yang X; Xie L; Shi H; Wang Z; Yin J; Zhan T; Shao Y; Chen C; Luo Q; Xu J; Zong Z; Wei X; Xiao W; Yu C; Zheng L
J Immunol Res; 2022; 2022():3210200. PubMed ID: 35211629
[TBL] [Abstract][Full Text] [Related]
3. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
4. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
5. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
[TBL] [Abstract][Full Text] [Related]
6. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sjögren's syndrome.
Ye L; Shi H; Yu C; Fu J; Chen C; Wu S; Zhan T; Wang B; Zheng L
Int Immunopharmacol; 2020 Nov; 88():106992. PubMed ID: 33182021
[TBL] [Abstract][Full Text] [Related]
7. IL-27 Regulated CD4
Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G
Front Immunol; 2020; 11():1699. PubMed ID: 32849596
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
9. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
[TBL] [Abstract][Full Text] [Related]
10. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
11. IL-17 and CCR9
Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
Front Immunol; 2021; 12():721453. PubMed ID: 34539657
[TBL] [Abstract][Full Text] [Related]
12. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
14. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
15. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
[TBL] [Abstract][Full Text] [Related]
16. The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.
Enger TB; Samad-Zadeh A; Bouchie MP; Skarstein K; Galtung HK; Mera T; Walker J; Menko AS; Varelas X; Faustman DL; Jensen JL; Kukuruzinska MA
Lab Invest; 2013 Nov; 93(11):1203-18. PubMed ID: 24080911
[TBL] [Abstract][Full Text] [Related]
17. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CD4 + T cells by fanchinoline via miR506-3p/NFATc1 in Sjögren's syndrome.
Shao Y; Fu J; Zhan T; Yin J; Xu J; Lu Y; Luo Q; Yu C
Inflammopharmacology; 2023 Oct; 31(5):2431-2443. PubMed ID: 37450074
[TBL] [Abstract][Full Text] [Related]
19. Targeting EZH2 prevents the occurrence and mitigates the development of Sjögren's syndrome in mice.
Zhu S; Liu M; Zhu F; Yu X; Wen J; Li C
Int Immunopharmacol; 2022 Sep; 110():109073. PubMed ID: 35978516
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
Zhou J; Zhang X; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166302. PubMed ID: 34780913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
